TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19940728

Group type: EXPERIMENTAL
Intervention: Laminectomy bone chips mixed with bone marrow aspirate (BMA)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Calcium sulfate pellets soaked in BMA
Number of subjects: 43

Group type: COMPARATOR
Intervention: Autologous iliac crest bone graft (ICBG)
Number of subjects: 43
Study: 16801582

Group type: EXPERIMENTAL
Intervention: High dairy intake (highest quintile)
Number of subjects: 37183

Group type: EXPERIMENTAL
Intervention: Each serving-per-day increase in dairy intake
Number of subjects: 37183

Group type: EXPERIMENTAL
Intervention: High low-fat dairy intake (highest quintile)
Number of subjects: 37183

Group type: EXPERIMENTAL
Intervention: Dairy intake (overall)
Number of subjects: 37183
Study: 16647363

Group type: EXPERIMENTAL
Intervention: Lecture on obtaining informed consent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stepwise training combined with consent training
Number of subjects: 0
Study: 14657822

Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 13

Group type: COMPARATOR
Intervention: Preterm infant formula
Number of subjects: 13
Study: 10081530

Group type: EXPERIMENTAL
Intervention: Continuous interscalene brachial plexus block with bupivacaine (1.25 mg kg‐1 + 0.25 mg kg‐1 h‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Morphine (5 mg i.m. and 2 mg i.v.)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Patient-controlled analgesia with morphine (bolus 1 mg)
Number of subjects: 30
Study: 7553233

Group type: EXPERIMENTAL
Intervention: Topical interferon-beta cream
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 2187327

Group type: EXPERIMENTAL
Intervention: Enteric-coated sodium fluoride tablets and calcium supplements
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Enteric-coated sodium fluoride tablets and calcium supplements with vitamin D
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (age- and sex-matched)
Number of subjects: 101
Study: 41455

Group type: EXPERIMENTAL
Intervention: Choline chloride (up to 20 g/day)
Number of subjects: 9
Study: 31811360

Group type: EXPERIMENTAL
Intervention: Twice-daily oral iron therapy (60 mg elemental iron twice daily)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Alternate-day oral iron therapy (120 mg iron on alternate days)
Number of subjects: 62
Study: 31206591

Group type: EXPERIMENTAL
Intervention: Intraperitoneal ropivacaine (Group IPLA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (Group P)
Number of subjects: 40
Study: 28829766

Group type: EXPERIMENTAL
Intervention: Incentive intervention (chance to win a £50 shopping voucher for returning a consent form)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard invitation arm
Number of subjects: 6
Study: 26132140

Group type: EXPERIMENTAL
Intervention: Zinc sulphate (50 mg/day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 23479454

Group type: EXPERIMENTAL
Intervention: Screening Arm (SA) - PSA determination up to three times with a 4-year interval.
Number of subjects: 80144

Group type: COMPARATOR
Intervention: Control Arm (CA) - Usual care.
Number of subjects: 80144
Study: 21696889

Group type: EXPERIMENTAL
Intervention: Tanezumab 200 μg/kg
Number of subjects: 217

Group type: COMPARATOR
Intervention: Naproxen 500 mg twice a day
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study: 19404631

Group type: EXPERIMENTAL
Intervention: Escitalopram 10 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 16542198

Group type: EXPERIMENTAL
Intervention: Saquinavir soft-gel capsules 1200 mg three times daily for 3 days
Number of subjects: 38
Study: 15307694

Group type: EXPERIMENTAL
Intervention: Compound Fructus Arctii Mixture (FAM)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Losartan (Control)
Number of subjects: 31
Study: 11124359

Group type: EXPERIMENTAL
Intervention: 5 mg 9-methylene PGE(2) vaginal gel (meteneprost)
Number of subjects: 893

Group type: COMPARATOR
Intervention: 600 microg oral PGE(1) (misoprostol)
Number of subjects: 893

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 893

Group type: EXPERIMENTAL
Intervention: Oral PGE(1) (misoprostol)
Number of subjects: 893

Group type: EXPERIMENTAL
Intervention: 9-methylene vaginal PGE(2) gel (meteneprost)
Number of subjects: 893
Study: 9310802

Group type: EXPERIMENTAL
Intervention: Sequential administration (SQA) of inhaled nitric oxide (NO) at 1, 3, and 6 ppm
Number of subjects: 13

Group type: COMPARATOR
Intervention: Continuous administration (CTA) of inhaled nitric oxide (NO) at 1, 3, and 6 ppm
Number of subjects: 13
Study: 8379713

Group type: EXPERIMENTAL
Intervention: Infusion of autologous platelet-rich plasma (PRP)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Infusion of autologous whole blood harvested immediately before cardiopulmonary bypass
Number of subjects: 100

Group type: COMPARATOR
Intervention: No intraoperative autologous blood conservation (control group)
Number of subjects: 100
Study: 2876576

Group type: EXPERIMENTAL
Intervention: ICI-118.551 (50 mg X 3)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: dl-propranolol (80 mg X 3)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (X 3)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: ICI-118.551 and dl-propranolol
Number of subjects: 18
Study: 31152196

Group type: EXPERIMENTAL
Intervention: Ureteral stent F4.7
Number of subjects: 181

Group type: COMPARATOR
Intervention: Ureteral stent F6
Number of subjects: 181

Group type: COMPARATOR
Intervention: Ureteral stent F7
Number of subjects: 181
Study: 30460369

Group type: EXPERIMENTAL
Intervention: Narrowband ultraviolet B phototherapy and topical corticosteroid
Number of subjects: 18

Group type: COMPARATOR
Intervention: Topical corticosteroid only
Number of subjects: 18
Study: 29158663

Group type: EXPERIMENTAL
Intervention: DA‐2802 (319 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: TDF (300 mg)
Number of subjects: 36
Study: 25719692

Group type: EXPERIMENTAL
Intervention: MT10109L
Number of subjects: 168

Group type: COMPARATOR
Intervention: Botox
Number of subjects: 168
Study: 23481084

Group type: EXPERIMENTAL
Intervention: Good Behavior Game (GBG)
Number of subjects: 570

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 570
Study: 21788624

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg
Number of subjects: 3488

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3488
Study: 19406293

Group type: EXPERIMENTAL
Intervention: Aquatic physiotherapy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Additional ward treatment
Number of subjects: 65

Group type: COMPARATOR
Intervention: Water exercise
Number of subjects: 65
Study: 16500346

Group type: EXPERIMENTAL
Intervention: Fallopian tube sperm perfusion (FSP) with 4 mL of inseminate
Number of subjects: 276

Group type: COMPARATOR
Intervention: Intrauterine tuboperitoneal insemination (IUTPI) with 10 mL of inseminate
Number of subjects: 276
Study: 15625998

Group type: EXPERIMENTAL
Intervention: Cincinnati Prehospital Stroke Scale (CPSS) administered by laypersons over the telephone
Number of subjects: 70
Study: 11583725

Group type: EXPERIMENTAL
Intervention: 40 mg fluvastatin twice daily
Number of subjects: 834

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 834
Study: 9741035

Group type: EXPERIMENTAL
Intervention: History of purging behavior (HP; N = 24)
Number of subjects: 63

Group type: COMPARATOR
Intervention: No history of purging behavior (NHP; N = 39)
Number of subjects: 63
Study: 8040674

Group type: EXPERIMENTAL
Intervention: Ifosfamide (IFOS) 2 g/m2/d for 4 days IV plus mesna
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Carboplatin (CARB) 560 mg/m2 IV over 1 hour
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Iproplatin (CHIP) 325 mg/m2 IV over 2 hours
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Epirubicin (EPIR) 90 mg/m2 IV push
Number of subjects: 173

Group type: COMPARATOR
Intervention: CECA (cisplatin 90 mg/m2 IV on day 1, etoposide 200 mg/m2 IV on day 3, cyclophosphamide 150 mg/m2/d orally on days 7 to 13, doxorubicin 35 mg/m2 IV on day 14)
Number of subjects: 173

Group type: COMPARATOR
Intervention: HDP/VP/CA (cisplatin 40 mg/m2 IV on days 1 to 5 and etoposide 200 mg/m2 IV on days 2 to 4 alternating with cyclophosphamide 150 mg/m2/d orally on days 1 to 7 and doxorubicin 35 mg/m2 IV on day 8)
Number of subjects: 173
Study: 2522265

Group type: EXPERIMENTAL
Intervention: Halothane anaesthesia (Group I)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Balanced anaesthesia (Group II)
Number of subjects: 16
Study: 30984974

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (1 × 10^10 cfu/d)
Number of subjects: 24
Study: 28259243

Group type: EXPERIMENTAL
Intervention: Conjoint Behavioral Consultation (CBC)
Number of subjects: 267
Study: 25989985

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection with physiotherapy
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Placebo injection with physiotherapy
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control (wait-and-see)
Number of subjects: 177
Study: 23716501

Group type: EXPERIMENTAL
Intervention: Moderate-intensity physical activity program
Number of subjects: 1635

Group type: COMPARATOR
Intervention: Successful aging health education program
Number of subjects: 1635
Study: 22054337

Group type: EXPERIMENTAL
Intervention: Tailored package of housing modifications (ventilation systems and central heating)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control group (no tailored package)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Tailored package of housing modifications
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Tailored package of housing modifications for children with 'severe' asthma
Number of subjects: 177
Study: 19234844

Group type: EXPERIMENTAL
Intervention: 20 mg famotidine in 10 ml saline
Number of subjects: 20

Group type: COMPARATOR
Intervention: 10 ml saline
Number of subjects: 20
Study: 16896939

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 15340803

Group type: EXPERIMENTAL
Intervention: Titanium disc spacers by Weber
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Titanium disc spacers by Intromed
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Carbonium spacers by AcroMed
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: AcoMed, Medinorm, and Intromed titanium spacers
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Titanium cage Cespace by Aesculap
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: PEEK spacer by Intromed
Number of subjects: 267
Study: 10770452

Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg/day
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sertraline 100 mg/day
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sertraline 150 mg/day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Alprazolam 1 mg orally
Number of subjects: 10
Study: 9125795

Group type: EXPERIMENTAL
Intervention: Alternate-day prednisone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Highly purified fish oil concentrate (Omacor®)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2015732

Group type: EXPERIMENTAL
Intervention: Cocaine administration
Number of subjects: 5
Study: 6832203

Group type: EXPERIMENTAL
Intervention: Paracetamol 1000 mg administered preoperatively
Number of subjects: 50

Group type: COMPARATOR
Intervention: Paracetamol 1000 mg administered postoperatively
Number of subjects: 50
Study: 31407353

Group type: EXPERIMENTAL
Intervention: Melatonin (1 mg per day for 1 month)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (NSPT and placebo capsules for 1 month)
Number of subjects: 20
Study: 30066262

Group type: EXPERIMENTAL
Intervention: Model-based approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Design-based approach
Number of subjects: 0
Study: 28478622

Group type: EXPERIMENTAL
Intervention: Chitosan pads
Number of subjects: 15

Group type: COMPARATOR
Intervention: Gauze pads
Number of subjects: 15
Study: 24964358

Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Ritonavir-boosted protease inhibitors (PI/r)
Number of subjects: 250
Study: 23591103

Group type: EXPERIMENTAL
Intervention: Onabotulinumtoxin-A injections
Number of subjects: 20

Group type: COMPARATOR
Intervention: Suction-curettage
Number of subjects: 20
Study: 21257146

Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2%
Number of subjects: 178

Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 178
Study: 19481566

Group type: EXPERIMENTAL
Intervention: Children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adults
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both children and adults
Number of subjects: 0
Study: 16398793

Group type: EXPERIMENTAL
Intervention: Child-focused smoking cessation intervention
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Maternal-focused smoking cessation intervention
Number of subjects: 363

Group type: COMPARATOR
Intervention: Control group (no smoking cessation advice)
Number of subjects: 363
Study: 15058848

Group type: EXPERIMENTAL
Intervention: Home-based intervention (HBI)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 152
Study: 11112196

Group type: EXPERIMENTAL
Intervention: Aprotinin (1.5 x 10(6) KIU)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 60
Study: 9424326

Group type: EXPERIMENTAL
Intervention: One-cycle cryosurgery
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Second cycle of cryosurgery
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Double freeze-thaw cycle
Number of subjects: 217
Study: 1644456

Group type: EXPERIMENTAL
Intervention: Bone biopsy at the time of surgery
Number of subjects: 81

Group type: COMPARATOR
Intervention: Previous study (20 years ago)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Histological screening and measurement of serum bone biochemistry
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Histologically detectable osteoporosis
Number of subjects: 81
Study: 6369348

Group type: EXPERIMENTAL
Intervention: Combined medication of 150 mg Chlorimipramine and 9 mg p.d. Haloperidol (given over six days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 20
Study: 2959232

Group type: EXPERIMENTAL
Intervention: Ramipril (10 mg p.o.)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 28755054

Group type: EXPERIMENTAL
Intervention: MRI features predictive of EGFR expression level
Number of subjects: 270
Study: 26660148

Group type: EXPERIMENTAL
Intervention: Rehabilitation
Number of subjects: 191

Group type: COMPARATOR
Intervention: Waiting list (Control)
Number of subjects: 191
Study: 24839882

Group type: EXPERIMENTAL
Intervention: JASP+EMT+SGD
Number of subjects: 61

Group type: COMPARATOR
Intervention: JASP+EMT
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: JASP+EMT+SGD (adaptive intervention)
Number of subjects: 61
Study: 23237817

Group type: EXPERIMENTAL
Intervention: Modified tumescent solution
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 10
Study: 20544159

Group type: EXPERIMENTAL
Intervention: Functional splint used during activities of daily living for 180 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group used the splint only during evaluations for the first 90 days and during activities of daily living for the following 90 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Functional splint
Number of subjects: 40
Study: 18656872

Group type: EXPERIMENTAL
Intervention: Active transducer with ultrasound stimulation (Exogen 2000)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo transducer
Number of subjects: 101
Study: 16083306

Group type: EXPERIMENTAL
Intervention: Very-Low-Calorie Diet (VLCD) for three weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Very-Low-Calorie Diet (VLCD)
Number of subjects: 14
Study: 12797711

Group type: EXPERIMENTAL
Intervention: Web-based (WB) format
Number of subjects: 75

Group type: COMPARATOR
Intervention: Paper (P) format
Number of subjects: 75

Group type: COMPARATOR
Intervention: Touch Screen (TS) format
Number of subjects: 75
Study: 10785529

Group type: EXPERIMENTAL
Intervention: Self-help leaflet offering cognitive-behavioural guidance
Number of subjects: 106
Study: 8899256

Group type: EXPERIMENTAL
Intervention: 150 mg depot‐medroxyprogesterone acetate (DMPA), intramuscularly on days 42 + 1 and 126 + 1 postpartum
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (infants of mothers who did not receive DMPA)
Number of subjects: 22
Study: 2060336

Group type: EXPERIMENTAL
Intervention: Heat and Moisture Exchanger (HME)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heated Humidifier (HH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HME
Number of subjects: 0

Group type: COMPARATOR
Intervention: HH
Number of subjects: 0
Study: 6418690

Group type: EXPERIMENTAL
Intervention: 1% sodium cromoglycate (SC) solution t.i.d. by means of a home nebulizer
Number of subjects: 22

Group type: COMPARATOR
Intervention: 2 ml placebo (water) nebulization
Number of subjects: 22
Study: 30122646

Group type: EXPERIMENTAL
Intervention: qHPV vaccine
Number of subjects: 3006
Study: 29449102

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate glue
Number of subjects: 71

Group type: COMPARATOR
Intervention: Filling gelfoam
Number of subjects: 71
Study: 27564281

Group type: EXPERIMENTAL
Intervention: Ultrasound guided csPCNL (group A)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Fluoroscopically guided csPCNL (group B)
Number of subjects: 51
Study: 24641742

Group type: EXPERIMENTAL
Intervention: Place and active hold exercises
Number of subjects: 54

Group type: COMPARATOR
Intervention: Controlled passive mobilization (modified Kleinert)
Number of subjects: 54
Study: 23213957

Group type: EXPERIMENTAL
Intervention: Experimental group (EG) - 8-week speed training program, 3 days a week
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CG) - no intervention
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Experimental group (EG) - 8-week speed training program
Number of subjects: 30
Study: 19671542

Group type: COMPARATOR
Intervention: guaiac-based faecal occult blood test (gFOBT)
Number of subjects: 15011

Group type: COMPARATOR
Intervention: immunochemical faecal occult blood test (FIT)
Number of subjects: 15011

Group type: COMPARATOR
Intervention: flexible sigmoidoscopy (FS)
Number of subjects: 15011
Study: 18042655

Group type: EXPERIMENTAL
Intervention: Variable feedback group (VAR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Constant feedback group (CON)
Number of subjects: 30
Study: 15860542

Group type: EXPERIMENTAL
Intervention: Generalized least squares and maximum likelihood methods for estimating piecewise density function and examination sensitivity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalized least squares and maximum likelihood methods
Number of subjects: 0
Study: 11154865

Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epinastine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9455696

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (30 mg per day for 1 month)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (for 1 month)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Incremental exercise to exhaustion
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation
Number of subjects: 14
Study: 7834163

Group type: EXPERIMENTAL
Intervention: Acidic urine conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alkaline urine conditions
Number of subjects: 0
Study: 3280304

Group type: EXPERIMENTAL
Intervention: Increasing the dose until the level reached and stayed at the therapeutic range (study arm B)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Keeping the level in the subtherapeutic range (study arm A)
Number of subjects: 79
Study: 31765047

Group type: EXPERIMENTAL
Intervention: Linked color imaging (LCI)
Number of subjects: 84

Group type: COMPARATOR
Intervention: White-light imaging (WLI)
Number of subjects: 84
Study: 31115626

Group type: EXPERIMENTAL
Intervention: Composite criteria using tumor size < 6.0 cm, tumor number < 8, alpha-fetoprotein < 465 ng/mL, TBRmax < 2.8
Number of subjects: 239

Group type: COMPARATOR
Intervention: Conventional recipient selection criteria
Number of subjects: 239
Study: 27472957

Group type: EXPERIMENTAL
Intervention: ProRoot MTA
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: OrthoMTA
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: RetroMTA
Number of subjects: 82
Study: 23553187

Group type: EXPERIMENTAL
Intervention: Obeldicks Light Training Programme
Number of subjects: 66
Study: 23977105

Group type: EXPERIMENTAL
Intervention: 24-hour shift (24 hS)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Self-reported stress
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Age of physicians
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control day (clerical work)
Number of subjects: 17
Study: 20537762

Group type: EXPERIMENTAL
Intervention: Sulfurous, salty, bromic, iodic (SSBI) thermal water
Number of subjects: 80

Group type: COMPARATOR
Intervention: Isotonic sodium chloride solution (ISCS)
Number of subjects: 80
Study: 19440013

Group type: EXPERIMENTAL
Intervention: Eutectic mixture of local anesthetics cream (EMLA)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (DS)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: EMLA+DS
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (not applicable)
Number of subjects: 120
Study: 17848798

Group type: EXPERIMENTAL
Intervention: Phantasy Therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Art Therapy (AT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo Group (PG)
Number of subjects: 0
Study: 15278255

Group type: EXPERIMENTAL
Intervention: Continent women
Number of subjects: 103

Group type: COMPARATOR
Intervention: Incontinent women
Number of subjects: 103
Study: 11589647

Group type: EXPERIMENTAL
Intervention: Losigamone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9010894

Group type: EXPERIMENTAL
Intervention: Nicotine gum and acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Double placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of one active treatment and placebo
Number of subjects: 0